Maxim Group analyst, Jason Kolbert, noted that Cytosorbents (NASDAQ: CTSO) announced a four-year term debt financing deal for $10M (effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE